Table of Contents 2
List of Tables 5
List of Figures 5
Sutro Biopharma, Inc. Spshot 6
Sutro Biopharma, Inc. Overview 6
Key Information 6
Key Facts 6
Sutro Biopharma, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Sutro Biopharma, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Sutro Biopharma, Inc. - Pipeline Products Glance 11
Sutro Biopharma, Inc. - Early Stage Pipeline Products 11
Discovery Products/Combition Treatment Modalities 11
Sutro Biopharma, Inc. - Drug Profiles 12
Monoclol Antibodies for Cancer 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Monoclol Antibodies for Oncology 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Monoclol Antibody Conjugate for Oncology 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Monoclol Antibody Conjugates 1 for Oncology 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Monoclol Antibody Conjugates 2 for Oncology 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Monoclol Antibody for Cancer 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Monoclol Antibody to Antagonize CTLA4 for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Monoclol Antibody to Inhibit LAG3 for Oncology 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Monoclol Antibody to Inhibit PD-1 for Cancer 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Monoclol Antibody to Inhibit PD-L1 for Oncology 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Monoclol Antibody to Inhibit TIM3 for Oncology 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Monoclol Antibody to Target CD3 for Neuroblastoma 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Monoclol Antibody to Target GD2 for Melanoma 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Monoclol Antibody to Target GD2 for Neuroblastoma 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclol Antibody to Target GD2 for Osteosarcoma 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Synthetic Peptide for Undisclosed Indication 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Sutro Biopharma, Inc. - Pipeline Alysis 28
Sutro Biopharma, Inc. - Pipeline Products by Target 28
Sutro Biopharma, Inc. - Pipeline Products by Molecule Type 29
Sutro Biopharma, Inc. - Pipeline Products by Mechanism of Action 30
Sutro Biopharma, Inc. - Recent Pipeline Updates 31
Sutro Biopharma, Inc. - Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 33
Disclaimer 34